Sekretessinställningar
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Aktiemarknader
    • BörsRealtidskurser, index och marknadsutveckling
    • MorgonrapportDaglig marknadssammanfattning och nattens viktigaste händelser
    • BörskalenderKommande resultat, noteringar och företagshändelser
    • UtdelningskalenderKommande och tidigare utdelningar
  • Bolag
    • BolagBläddra och filtrera hela listan över noterade bolag
    • UpptäckInspiration till din nästa investering
    • BörsnoteringarNya noteringar och kommande börsintroduktioner
    • ÅrsstämmorDatum för årsstämmor och aktieägarinformation
  • Aktieforskning
    • AktieanalysExpertaktieanalys och rekommendationer
    • ArtiklarNyheter, insikter och marknadskommentarer
    • PortföljInderes modellportfölj
    • inderesTVVideohub för aktieanalys, forskning och expertkommentarer
    • TranskriptionerFullständiga utskrifter av resultatsamtal och investerarmöten
    • AktiejämförelseJämför nyckeltal och utveckling för flera aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • BlankningSe vilka börsnoterade bolag som har offentliggjorda korta positioner
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Q&A
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer

Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

Getinge appoints Stacy Beske as President Acute Care Therapies

GETI BRegulatoriskt pressmeddelande2026-11-09 16:00
Ladda ner börsmeddelandet

Getinge has appointed Stacy Beske as President Acute Care Therapies and member of the Executive Team, reporting to Mattias Perjos, President & CEO. She will assume the position on December 1, 2026.

Beske joins Getinge from Philips where she most recently served as Senior Vice President, Business Unit Leader for Image Guided Therapy Devices. She holds a Ph.D. in Cardiovascular Physiology, has an extensive research background, and brings 20+ years of leadership experience across medtech, including image-guided therapy, diabetes, electrophysiology, diagnostics, and cardiovascular care.

"Stacy has a strong track record of leading complex businesses and transformations, building high-performing teams and turning strategy into results," says Mattias Perjos, President & CEO at Getinge. "This experience will be valuable as we deliver on our commitment to continue strengthening Acute Care Therapies by building on the progress made in recent years."

"I am very excited to join Getinge and to be leading Acute Care Therapies," says Beske. "The business has a strong portfolio and a crucial role in helping healthcare professionals improve outcomes for patients. I look forward to working with my new colleagues across the globe to build on that foundation, accelerate innovation and continue advancing the business."

Stacy Beske will be based at Getinge's office in Wayne, New Jersey. She succeeds Elin Frostehav, who will leave Getinge to take on an external opportunity after supporting a smooth transition.

Media contact:

Caroline Örmgård, Head of Media Relations
Phone: +46 (0)10 335 0041
Email: caroline.ormgard@getinge.com

About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.